SEC Form 4 · accession 0001645470-19-000001
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan Brian Collier
Officer — CEO
Period of report
Jun 20, 2016
Accepted (ET)
Jan 14, 2019 · 12:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 20, 2016 | P$0 | 1,000,000 | $0.00 | A | 20,226,657 | D | |
| Common Stock | Jan 9, 2019 | P | 10,000 | $0.0189 | A | 20,236,657 | D | |
| Common Stock | Jan 9, 2019 | P | 10,000 | $0.0188 | A | 20,246,657 | D | |
| Common Stock | Jan 9, 2019 | P | 10,000 | $0.019 | A | 20,256,657 | D | |
| Common Stock | Jan 9, 2019 | P | 5,000 | $0.019 | A | 20,261,657 | D | |
| Common Stock | Jan 9, 2019 | P | 5,000 | $0.019 | A | 20,266,657 | D | |
| Common Stock | Jan 9, 2019 | P | 5,000 | $0.019 | A | 20,271,657 | D |
Table II — derivative securities
No Table II lines on this filing.